Mikhail Zibinsky

2PUBLICATIONS
1CO-AUTHORS
Tumour immunologyBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jul 14, 2026
Discovery of Tivumecirnon (FLX475), a Potent and Selective CCR4 Antagonist That Inhibits the Migration of Immunosuppressive Regulatory T Cells into the Tumor Microenvironment to Restore Antitumor Immunity.

|Jan 23, 2026
Discovery and Characterization of Zelnecirnon (RPT193), a Potent and Selective CCR4 Antagonist for Allergic Disorders.

Mikhail Zibinsky, Delia Bradford, Dirk G Brockstedt

Pageof 1

Frequent Collaborators

1 joint publications

Omar Robles